Abiraterone Tablets
Prostate Cancer
250mg
Abiraterone 250mg tablets, used in the management of prostate cancer. A CYP17A1 inhibitor that blocks androgen synthesis in the adrenal glands.
From$3.15/ tabletView
Abiraterone
Abiraterone reduces androgen production and is used as part of specialist treatment for selected Prostate Cancer. It is normally prescribed within a regimen that includes other hormonal treatment and a corticosteroid.
Key points
- Abiraterone is not used as a stand-alone self-treatment; the oncology regimen and companion medicines are clinically important.
- Blood pressure, potassium, fluid retention and liver tests require monitoring during treatment.
- Product-specific food instructions matter because food can substantially alter abiraterone exposure.
Listings are for comparison and general information, not an oncology regimen; suitability and supply depend on specialist, clinician and pharmacy checks, exact-product instructions, monitoring and prescription requirements.
How abiraterone works
Abiraterone inhibits CYP17, an enzyme needed for androgen production in the testes, adrenal glands and prostate tumour tissue. Lower androgen levels can slow androgen-sensitive cancer, but enzyme inhibition can also alter steroid balance and cause high blood pressure, low potassium or fluid retention.
Important safety checks
The oncology team reviews liver function, blood pressure, potassium, heart disease, swelling and interacting medicines. The companion corticosteroid should not be changed or stopped without specialist advice. Pregnancy-prevention and handling advice may apply because the medicine can harm a developing fetus.
When to seek urgent care
Contact the treating team urgently for severe weakness, muscle twitching, a fast or irregular heartbeat, fainting, rapid swelling, breathing difficulty, jaundice, dark urine or severe abdominal pain. Acute illness or inability to take the companion steroid also needs prompt advice.